Dr. Michael Zimmermann leads the Zimmermann Group at EMBL Heidelberg, where he investigates how gut microbiota metabolize drugs, nutrients, and environmental compounds—and how this shapes host physiology. Since August 2019, he has headed this research unit, supported by a prestigious ERC Starting Grant. He received his PhD in 2015 from ETH Zurich (metabolomics and systems …
Dr. Zaugg leads a cross-disciplinary research group at EMBL since 2014, exploring how genetics, epigenetics, and environmental signals integrate to shape gene regulatory programs underlying complex human traits and diseases. She earned her PhD in computational functional genomics from EMBL-EBI and Cambridge University (2011), followed by a postdoctoral fellowship at Stanford University (2012–2014), where she …
Prof. Johannes Betge is a is a physician-scientist, head of the Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models at the German Cancer Research Center (DKFZ) and attending physician in gastroenterology at University Medical Center Mannheim. Prof. Betge earned his doctoral degree at Heidelberg University and completed clinical training in internal medicine at …
Prof. Zhan earned his MD from Heidelberg University in 2011 and began his internal medicine training at UMM that same year. From 2013 to 2018, he conducted postdoctoral research in Signaling and Functional Genomics at the German Cancer Research Center in Heidelberg. Since 2019, he has been part of the DFG-funded Clinician Scientist Program and …